The token value is driven by their utility in relation to the initial market offering available on the platform and the BIOSPHERES potential market offering. Aevolve’s market is designed to function primarily at a high utility value and minimize speculation over time. Aevolve is driven by actual medical solutions and products that address real-world demand and practical applications. AVEX! and SPHERE asset ownership are targeted towards patient-consumers.